Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

UK Dental Prosthetics Market

ID: MRFR/HC/20035-CR
81 Pages
Satyendra Maurya
Last Updated: April 02, 2026

UK Dental Prosthetics Market Research Report Information by Mode of Operations (Traditional Dental Prosthetics and Digital Dental Prosthetics), by Product Type (Dental Bridges, Dental Crowns, Dentures, Veneers, and Abutments), and by End User (Hospitals & Dental Clinics and Dental Laboratories) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

UK Dental Prosthetics Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Pharmaceutical, BY Type (USD Million)
  49.     4.1.1 Dentures
  50.     4.1.2 Crowns
  51.     4.1.3 Bridges
  52.     4.1.4 Veneers
  53.     4.1.5 Abutments
  54.     4.1.6 Inlays
  55.   4.2 Pharmaceutical, BY Type of Material (USD Million)
  56.     4.2.1 Porcelain-Fused-to-Metal
  57.     4.2.2 All-Ceramic
  58.     4.2.3 Others
  59.   4.3 Pharmaceutical, BY End User (USD Million)
  60.     4.3.1 Dental Hospitals & Clinics
  61.     4.3.2 Dental Laboratories
  62. 5 SECTION V: COMPETITIVE ANALYSIS
  63.   5.1 Competitive Landscape
  64.     5.1.1 Overview
  65.     5.1.2 Competitive Analysis
  66.     5.1.3 Market share Analysis
  67.     5.1.4 Major Growth Strategy in the Pharmaceutical
  68.     5.1.5 Competitive Benchmarking
  69.     5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  70.     5.1.7 Key developments and growth strategies
  71.       5.1.7.1 New Product Launch/Service Deployment
  72.       5.1.7.2 Merger & Acquisitions
  73.       5.1.7.3 Joint Ventures
  74.     5.1.8 Major Players Financial Matrix
  75.       5.1.8.1 Sales and Operating Income
  76.       5.1.8.2 Major Players R&D Expenditure. 2023
  77.   5.2 Company Profiles
  78.     5.2.1 Dentsply Sirona (US)
  79.       5.2.1.1 Financial Overview
  80.       5.2.1.2 Products Offered
  81.       5.2.1.3 Key Developments
  82.       5.2.1.4 SWOT Analysis
  83.       5.2.1.5 Key Strategies
  84.     5.2.2 Straumann (CH)
  85.       5.2.2.1 Financial Overview
  86.       5.2.2.2 Products Offered
  87.       5.2.2.3 Key Developments
  88.       5.2.2.4 SWOT Analysis
  89.       5.2.2.5 Key Strategies
  90.     5.2.3 Align Technology (US)
  91.       5.2.3.1 Financial Overview
  92.       5.2.3.2 Products Offered
  93.       5.2.3.3 Key Developments
  94.       5.2.3.4 SWOT Analysis
  95.       5.2.3.5 Key Strategies
  96.     5.2.4 Nobel Biocare (CH)
  97.       5.2.4.1 Financial Overview
  98.       5.2.4.2 Products Offered
  99.       5.2.4.3 Key Developments
  100.       5.2.4.4 SWOT Analysis
  101.       5.2.4.5 Key Strategies
  102.     5.2.5 Henry Schein (US)
  103.       5.2.5.1 Financial Overview
  104.       5.2.5.2 Products Offered
  105.       5.2.5.3 Key Developments
  106.       5.2.5.4 SWOT Analysis
  107.       5.2.5.5 Key Strategies
  108.     5.2.6 3M (US)
  109.       5.2.6.1 Financial Overview
  110.       5.2.6.2 Products Offered
  111.       5.2.6.3 Key Developments
  112.       5.2.6.4 SWOT Analysis
  113.       5.2.6.5 Key Strategies
  114.     5.2.7 GC Corporation (JP)
  115.       5.2.7.1 Financial Overview
  116.       5.2.7.2 Products Offered
  117.       5.2.7.3 Key Developments
  118.       5.2.7.4 SWOT Analysis
  119.       5.2.7.5 Key Strategies
  120.     5.2.8 Kuraray Noritake Dental (JP)
  121.       5.2.8.1 Financial Overview
  122.       5.2.8.2 Products Offered
  123.       5.2.8.3 Key Developments
  124.       5.2.8.4 SWOT Analysis
  125.       5.2.8.5 Key Strategies
  126.   5.3 Appendix
  127.     5.3.1 References
  128.     5.3.2 Related Reports
  129. 6 LIST OF FIGURES
  130.   6.1 MARKET SYNOPSIS
  131.   6.2 UK MARKET ANALYSIS BY TYPE
  132.   6.3 UK MARKET ANALYSIS BY TYPE OF MATERIAL
  133.   6.4 UK MARKET ANALYSIS BY END USER
  134.   6.5 KEY BUYING CRITERIA OF PHARMACEUTICAL
  135.   6.6 RESEARCH PROCESS OF MRFR
  136.   6.7 DRO ANALYSIS OF PHARMACEUTICAL
  137.   6.8 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
  138.   6.9 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
  139.   6.10 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
  140.   6.11 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
  141.   6.12 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
  142.   6.13 PHARMACEUTICAL, BY TYPE OF MATERIAL, 2024 (% SHARE)
  143.   6.14 PHARMACEUTICAL, BY TYPE OF MATERIAL, 2024 TO 2035 (USD Million)
  144.   6.15 PHARMACEUTICAL, BY END USER, 2024 (% SHARE)
  145.   6.16 PHARMACEUTICAL, BY END USER, 2024 TO 2035 (USD Million)
  146.   6.17 BENCHMARKING OF MAJOR COMPETITORS
  147. 7 LIST OF TABLES
  148.   7.1 LIST OF ASSUMPTIONS
  149.     7.1.1
  150.   7.2 UK MARKET SIZE ESTIMATES; FORECAST
  151.     7.2.1 BY TYPE, 2025-2035 (USD Million)
  152.     7.2.2 BY TYPE OF MATERIAL, 2025-2035 (USD Million)
  153.     7.2.3 BY END USER, 2025-2035 (USD Million)
  154.   7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  155.     7.3.1
  156.   7.4 ACQUISITION/PARTNERSHIP
  157.     7.4.1

UK Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

  • Dentures
  • Crowns
  • Bridges
  • Veneers
  • Abutments
  • Inlays

Pharmaceutical By Type of Material (USD Million, 2025-2035)

  • Porcelain-Fused-to-Metal
  • All-Ceramic
  • Others

Pharmaceutical By End User (USD Million, 2025-2035)

  • Dental Hospitals & Clinics
  • Dental Laboratories

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions